z-logo
open-access-imgOpen Access
Latent Multi-drug Resistant Tuberculosis: An Unaddressed Problem
Author(s) -
Gyanshankar Mishra,
Jasmin Mulani
Publication year - 2020
Publication title -
archives of pulmonology and respiratory care
Language(s) - English
Resource type - Journals
ISSN - 2581-3684
DOI - 10.17352/aprc.000063
Subject(s) - latent tuberculosis , tuberculosis , medicine , extensively drug resistant tuberculosis , multiple drug resistance , drug , drug resistance , drug resistant tuberculosis , virology , mycobacterium tuberculosis , immunology , pharmacology , biology , microbiology and biotechnology , pathology
It is estimated that three of every 1,000 individuals worldwide have latent Multidrug-Resistant Tuberculosis (MDR-TB) infection. Management of latent MDR-TB is an integral component in our strategies targeting global TB elimination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom